Balyasny Asset Management LLC Maravai Lifesciences Holdings, Inc. Transaction History
Balyasny Asset Management LLC
- $58 Billion
- Q3 2024
A detailed history of Balyasny Asset Management LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 315,686 shares of MRVI stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
315,686
Previous 53,438
490.75%
Holding current value
$1.74 Million
Previous $382,000
586.65%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MRVI
# of Institutions
234Shares Held
140MCall Options Held
223KPut Options Held
19.4K-
Gtcr LLC20.2MShares$111 Million13.05% of portfolio
-
12 West Capital Management LP New York, NY14MShares$77.1 Million12.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$65.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$53.5 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$45.9 Million1.97% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $723M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...